Cocrystal Pharma, Inc.

COCP · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$9,860$26,353$37,144$58,705
Short-Term Investments$0$0$0$0
Receivables$1,215$890$716$0
Inventory$0$0$0$0
Other Curr. Assets$505$1,848$2,318$618
Total Curr. Assets$11,580$29,091$40,178$59,323
Property Plant & Equip (Net)$1,847$2,122$616$931
Goodwill$0$0$0$19,092
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$29$46$46$46
Total NC Assets$1,876$2,168$662$20,069
Other Assets$0$0$0$0
Total Assets$13,456$31,259$40,840$79,392
Liabilities
Payables$1,542$1,222$614$578
Short-Term Debt$301$240$240$236
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$585$1,800$362$731
Total Curr. Liab.$2,428$3,262$1,216$1,545
LT Debt$1,505$1,613$57$298
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$1,505$1,613$57$298
Other Liabilities$0$0$0$0
Cap. Leases$1,806$1,853$297$534
Total Liabilities$3,933$4,875$1,273$1,843
Equity
Pref Stock$0$0$0$0
Common Stock$10$10$8$8
Retained Earnings-$333,418-$315,914-$297,930-$259,093
AOCI$0$0$0$0
Other Equity$342,931$342,288$337,489$336,634
Total Equity$9,523$26,384$39,567$77,549
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$13,456$31,259$40,840$79,392
Net Debt-$8,054-$24,500-$36,847-$58,171